15-61854399-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_020821.3(VPS13C):c.*58G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0702 in 1,469,670 control chromosomes in the GnomAD database, including 3,994 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.058 ( 314 hom., cov: 32)
Exomes 𝑓: 0.072 ( 3680 hom. )
Consequence
VPS13C
NM_020821.3 3_prime_UTR
NM_020821.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.467
Genes affected
VPS13C (HGNC:23594): (vacuolar protein sorting 13 homolog C) Involved in mitochondrion organization and negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization. Located in cytosol and mitochondrial outer membrane. Implicated in Parkinson's disease 23. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 15-61854399-C-T is Benign according to our data. Variant chr15-61854399-C-T is described in ClinVar as [Benign]. Clinvar id is 1238891.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0779 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS13C | NM_020821.3 | c.*58G>A | 3_prime_UTR_variant | 85/85 | ENST00000644861.2 | NP_065872.1 | ||
VPS13C | NM_017684.5 | c.*58G>A | 3_prime_UTR_variant | 83/83 | NP_060154.3 | |||
LOC124903501 | XR_007064668.1 | n.159+4927C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS13C | ENST00000644861 | c.*58G>A | 3_prime_UTR_variant | 85/85 | NM_020821.3 | ENSP00000493560.2 |
Frequencies
GnomAD3 genomes AF: 0.0580 AC: 8821AN: 152076Hom.: 314 Cov.: 32
GnomAD3 genomes
AF:
AC:
8821
AN:
152076
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0717 AC: 94416AN: 1317476Hom.: 3680 Cov.: 20 AF XY: 0.0719 AC XY: 47647AN XY: 662858
GnomAD4 exome
AF:
AC:
94416
AN:
1317476
Hom.:
Cov.:
20
AF XY:
AC XY:
47647
AN XY:
662858
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0579 AC: 8818AN: 152194Hom.: 314 Cov.: 32 AF XY: 0.0559 AC XY: 4159AN XY: 74426
GnomAD4 genome
AF:
AC:
8818
AN:
152194
Hom.:
Cov.:
32
AF XY:
AC XY:
4159
AN XY:
74426
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
170
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 20, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at